Literature DB >> 33540645

Iron Metabolism in the Tumor Microenvironment-Implications for Anti-Cancer Immune Response.

Alessandro Sacco1, Anna Martina Battaglia1, Cirino Botta2, Ilenia Aversa1, Serafina Mancuso3, Francesco Costanzo1,4, Flavia Biamonte1,4.   

Abstract

New insights into the field of iron metabolism within the tumor microenvironment have been uncovered in recent years. Iron promotes the production of reactive oxygen species, which may either trigger ferroptosis cell death or contribute to malignant transformation. Once transformed, cancer cells divert tumor-infiltrating immune cells to satisfy their iron demand, thus affecting the tumor immunosurveillance. In this review, we highlight how the bioavailability of this metal shapes complex metabolic pathways within the tumor microenvironment and how this affects both tumor-associated macrophages and tumor-infiltrating lymphocytes functions. Furthermore, we discuss the potentials as well as the current clinical controversies surrounding the use of iron metabolism as a target for new anticancer treatments in two opposed conditions: i) the "hot" tumors, which are usually enriched in immune cells infiltration and are extremely rich in iron availability within the microenvironment, and ii) the "cold" tumors, which are often very poor in immune cells, mainly due to immune exclusion.

Entities:  

Keywords:  adaptive immune response tumor microenvironment; cancer; ferroptosis; innate immune response; iron metabolism

Year:  2021        PMID: 33540645      PMCID: PMC7913036          DOI: 10.3390/cells10020303

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  155 in total

1.  Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer.

Authors:  E D Kwon; A A Hurwitz; B A Foster; C Madias; A L Feldhaus; N M Greenberg; M B Burg; J P Allison
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

2.  Identification of a subpopulation of macrophages in mammary tumor-bearing mice that are neither M1 nor M2 and are less differentiated.

Authors:  Marta Torroella-Kouri; Risset Silvera; Dayron Rodriguez; Raul Caso; Alwi Shatry; Shannon Opiela; Dan Ilkovitch; Reto A Schwendener; Vijaya Iragavarapu-Charyulu; Yoslayma Cardentey; Natasa Strbo; Diana M Lopez
Journal:  Cancer Res       Date:  2009-05-19       Impact factor: 12.701

3.  Induction of apoptosis by iron depletion in the human breast cancer MCF-7 cell line and the 13762NF rat mammary adenocarcinoma in vivo.

Authors:  Xian P Jiang; Fen Wang; Ding C Yang; Robert L Elliott; Jonathan F Head
Journal:  Anticancer Res       Date:  2002 Sep-Oct       Impact factor: 2.480

4.  Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease.

Authors:  John D Belcher; Chunsheng Chen; Julia Nguyen; Liming Milbauer; Fuad Abdulla; Abdu I Alayash; Ann Smith; Karl A Nath; Robert P Hebbel; Gregory M Vercellotti
Journal:  Blood       Date:  2013-11-25       Impact factor: 22.113

5.  Eukaryotic DNA polymerases require an iron-sulfur cluster for the formation of active complexes.

Authors:  Daili J A Netz; Carrie M Stith; Martin Stümpfig; Gabriele Köpf; Daniel Vogel; Heide M Genau; Joseph L Stodola; Roland Lill; Peter M J Burgers; Antonio J Pierik
Journal:  Nat Chem Biol       Date:  2011-11-27       Impact factor: 15.040

6.  Differential effects of Fe2+ and Fe3+ on osteoblasts and the effects of 1,25(OH)2D3, deferiprone and extracellular calcium on osteoblast viability under iron-overloaded conditions.

Authors:  Kornkamon Lertsuwan; Ketsaraporn Nammultriputtar; Supanan Nanthawuttiphan; Natnicha Tannop; Jarinthorn Teerapornpuntakit; Jirawan Thongbunchoo; Narattaphol Charoenphandhu
Journal:  PLoS One       Date:  2020-05-29       Impact factor: 3.240

7.  Fatty acid transport protein 2 reprograms neutrophils in cancer.

Authors:  Filippo Veglia; Vladimir A Tyurin; Maria Blasi; Alessandra De Leo; Andrew V Kossenkov; Laxminarasimha Donthireddy; Tsun Ki Jerrick To; Zach Schug; Subhasree Basu; Fang Wang; Emanuela Ricciotti; Concetta DiRusso; Maureen E Murphy; Robert H Vonderheide; Paul M Lieberman; Charles Mulligan; Brian Nam; Neil Hockstein; Gregory Masters; Michael Guarino; Cindy Lin; Yulia Nefedova; Paul Black; Valerian E Kagan; Dmitry I Gabrilovich
Journal:  Nature       Date:  2019-04-17       Impact factor: 49.962

8.  Improved survival outcomes and restoration of graft-vs-leukemia effect by deferasirox after allogeneic stem cell transplantation in acute myeloid leukemia.

Authors:  Byung-Sik Cho; Young-Woo Jeon; A-Reum Hahn; Tai-Hyang Lee; Sung-Soo Park; Jae-Ho Yoon; Sung-Eun Lee; Ki-Seong Eom; Yoo-Jin Kim; Seok Lee; Chang-Ki Min; Seok-Goo Cho; Jong-Wook Lee; Woo-Sung Min; Hee-Je Kim
Journal:  Cancer Med       Date:  2019-01-24       Impact factor: 4.452

9.  Iron Induces Anti-tumor Activity in Tumor-Associated Macrophages.

Authors:  Milene Costa da Silva; Michael O Breckwoldt; Francesca Vinchi; Margareta P Correia; Ana Stojanovic; Carl Maximilian Thielmann; Michael Meister; Thomas Muley; Arne Warth; Michael Platten; Matthias W Hentze; Adelheid Cerwenka; Martina U Muckenthaler
Journal:  Front Immunol       Date:  2017-11-08       Impact factor: 7.561

10.  H-Ferritin Affects Cisplatin-Induced Cytotoxicity in Ovarian Cancer Cells through the Modulation of ROS.

Authors:  Alessandro Salatino; Ilenia Aversa; Anna Martina Battaglia; Alessandro Sacco; Anna Di Vito; Gianluca Santamaria; Roberta Chirillo; Pierangelo Veltri; Giuseppe Tradigo; Annalisa Di Cello; Roberta Venturella; Flavia Biamonte; Francesco Costanzo
Journal:  Oxid Med Cell Longev       Date:  2019-10-31       Impact factor: 6.543

View more
  15 in total

1.  Hepcidin as a prognostic biomarker in clear cell renal cell carcinoma.

Authors:  Zijian Zhou; Jiajin Wu; Yuanyuan Yang; Peng Gao; Lujia Wang; Zhong Wu
Journal:  Am J Cancer Res       Date:  2022-09-15       Impact factor: 5.942

Review 2.  Orchestrated Action of AMPK Activation and Combined VEGF/PD-1 Blockade with Lipid Metabolic Tunning as Multi-Target Therapeutics against Ovarian Cancers.

Authors:  Mingo M H Yung; Michelle K Y Siu; Hextan Y S Ngan; David W Chan; Karen K L Chan
Journal:  Int J Mol Sci       Date:  2022-06-20       Impact factor: 6.208

3.  An Integrated Systematic Analysis and the Clinical Significance of Hepcidin in Common Malignancies of the Male Genitourinary System.

Authors:  Xiaogang Wang; Qianqian Shi; Pengfeng Gong; Cuixing Zhou; Yunjie Cao
Journal:  Front Genet       Date:  2022-05-12       Impact factor: 4.772

4.  Iron Administration Overcomes Resistance to Erastin-Mediated Ferroptosis in Ovarian Cancer Cells.

Authors:  Anna Martina Battaglia; Alessandro Sacco; Ida Daniela Perrotta; Maria Concetta Faniello; Mariangela Scalise; Daniele Torella; Sonia Levi; Francesco Costanzo; Flavia Biamonte
Journal:  Front Oncol       Date:  2022-03-31       Impact factor: 6.244

5.  A Nomogram Based on Circulating CD4+ T Lymphocytes and Lactate Dehydrogenase to Predict Distant Metastasis in Patients with Nasopharyngeal Carcinoma.

Authors:  De-Song Shen; Chang Yan; Kai-Hua Chen; Ling Li; Song Qu; Xiao-Dong Zhu
Journal:  J Inflamm Res       Date:  2021-12-09

6.  The Membrane Electrical Potential and Intracellular pH as Factors Influencing Intracellular Ascorbate Concentration and Their Role in Cancer Treatment.

Authors:  Mateusz Gąbka; Paulina Dałek; Magdalena Przybyło; Daniel Gackowski; Ryszard Oliński; Marek Langner
Journal:  Cells       Date:  2021-10-30       Impact factor: 6.600

7.  M5C regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in lung adenocarcinoma.

Authors:  Hui Chen; Xiao-Lin Ge; Zhao-Yue Zhang; Ming Liu; Rui-Yan Wu; Xiao-Fei Zhang; Li-Ping Xu; Hong-Yan Cheng; Xin-Chen Sun; Hong-Cheng Zhu
Journal:  Transl Lung Cancer Res       Date:  2021-05

Review 8.  Mechanisms of Immune Evasion in Multiple Myeloma: Open Questions and Therapeutic Opportunities.

Authors:  Cirino Botta; Francesco Mendicino; Enrica Antonia Martino; Ernesto Vigna; Domenica Ronchetti; Pierpaolo Correale; Fortunato Morabito; Antonino Neri; Massimo Gentile
Journal:  Cancers (Basel)       Date:  2021-06-28       Impact factor: 6.639

9.  Myositis/Myasthenia after Pembrolizumab in a Bladder Cancer Patient with an Autoimmunity-Associated HLA: Immune-Biological Evaluation and Case Report.

Authors:  Cirino Botta; Rita Maria Agostino; Vincenzo Dattola; Vittoria Cianci; Natale Daniele Calandruccio; Giovanna Bianco; Antonino Mafodda; Roberto Maisano; Eleonora Iuliano; Giovanna Orizzonte; Domenico Mazzacuva; Antonia Consuelo Falzea; Rita Emilena Saladino; Rocco Giannicola; Giorgio Restifo; Umberto Aguglia; Michele Caraglia; Pierpaolo Correale
Journal:  Int J Mol Sci       Date:  2021-06-10       Impact factor: 5.923

10.  Editorial: Iron Metabolism at the Crossroad of Innate Immune Response and Cancer Progression.

Authors:  Paola Zacchi; Stefania Recalcati
Journal:  Front Immunol       Date:  2022-01-05       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.